MedTrace Logo

Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women

NCT00545116 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2015-10-06

No results posted yet for this study

Summary

The primary objective of this clinical trial is to determine the effects of hesperidin on biochemical markers of bone in post-menopausal women.

The secondary objectives are:

* To investigate changes in bone formation and bone resorption markers in response to hesperidin intake
* To compare the efficacy of hesperidin in a milk versus biscuit
* To collect safety information of hesperidin consumption in a human trial

Conditions

Interventions

OTHER

Hesperidin

250 mg of hesperidin twice a day taken oraly in a biscuit or in milk for 6 months

Sponsors & Collaborators

  • National University of Malaysia

    collaborator OTHER

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Winnie Chee, PhD · Faculty of Allied Health Sciences, UKM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00545116 on ClinicalTrials.gov